Ellipsometry Analytical Complex for Measuring near the Surface Plasmon Resonance in Colorectal Cancer Diagnosis

Kruchinin V.N., Kruchinina M.V., Prudnikova Ya.I., Spesivtsev E.V., Rykhlitskiy S.V., Peltek S.E., Shehovtsov S.V., Shuvalov G.V.

Key words: cancer diagnostics; colorectal cancer; ellipsometry; surface plasmon resonance; tumor M2-pyruvate kinase.

2019, volume 11, issue 2, page 69.

DOI: https://doi.org/10.17691/stm2019.11.2.10

Full text

html pdf

1906

1623

Abstract
References
How to cite

The aim of the study was to assess the ellipsometry analytical complex for its diagnostic potential related to colorectal cancer and metastases of different localization. The proposed ellipsometry was aimed to complement the current non-invasive optical methods based on the reflection of polarized light near the surface plasmon resonance under full internal reflection.

Materials and Methods. We measured the highly specific and sensitive reaction between tumor-associated M2-pyruvate kinase and the respective monoclonal antibodies immobilized on chips. The biological material (blood serum) was obtained from healthy (cancer-free) subjects (n=19) and from patients with colorectal cancer of various localizations (n=49). The examined patients were divided into three subgroups depending on localization of the metastases: 1^st subgroup — local-regional colorectal cancer (n=15); 2^nd subgroup — hepatic metastases only (n=18); 3^rd subgroup — extrahepatic metastases (n=16). We also determined the concentrations of tumor M2-pyruvate kinase during its interaction with the monoclonal antibodies. In this, we measured the refractive index of the chip near-surface area by using highly sensitive optical systems able to measure the light polarization near the surface plasmon resonance.

Results. The interaction of serum M2-pyruvate kinase with the antibodies leads to a noticeable change in the optical properties of the medium, which indicates a high specificity of this reaction. We found significant differences (>20-fold) in the equilibrium levels of serum M2-pyruvate kinase both in healthy individuals and in patients with colorectal cancer, as well as in patients with metastases of various localizations. The diagnostic potential of these optical methods in respect to cancer-specific serum M2-pyruvate kinase as a marker of colorectal cancer was confirmed by subsequent ROC analysis.

Conclusion. The results obtained are promising for the development of methods for early diagnosis of colorectal cancer, for the detection of metastases of various locations, and (in the long term) for the detection of the recurrent disease, as well as for the treatment follow-up.

Fedorov V.E., Podelyakin K.A. Epidemiological aspects of colorectal cancer. Medicinskij alʹmanah 2017; 4: 145–148, https://doi.org/10.21145/2499-9954-2017-4-145-148.
Pathak S., Pandanaboyana S., Daniels I., Smart N., Prasad K.R. Obesity and colorectal liver metastases: mechanisms and management. Surg Oncol 2016; 25(3): 246–251, https://doi.org/10.1016/j.suronc.2016.05.021.
Stagnitti A., Barchetti F., Barchetti G., Pasqualitto E., Sartori A., Glorioso M., Gigli S., Buonocore V., Monti M.L., Marini A., Mele C., Stagnitti F., Laghi A. Preoperative staging of colorectal cancer using virtual colonoscopy: correlation with surgical results. Eur Rev Med Pharmacol Sci 2015; 19(9): 1645–1651.
Meyerhardt J.A., Mangu P.B., Flynn P.J., Korde L., Loprinzi C.L., Minsky B.D., Petrelli N.J., Ryan K., Schrag D.H., Wong S.L., Benson A.B. 3rd.; American Society of Clinical Oncology. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol 2013; 31(35): 4465–4470, https://doi.org/10.1200/jco.2013.50.7442.
Hamilton T.D., Leugner D., Kopciuk K., Dixon E., Sutherland F.R., Bathe O.F. Identification of prognostic inflammatory factors in colorectal liver metastases. BMC Cancer 2014; 14: 542, https://doi.org/10.1186/1471-2407-14-542.
Sasaki K., Andreatos N., Margonis G.A., He J., Weiss M., Johnston F., Wolfgang C., Antoniou E., Pikoulis E., Pawlik T.M. The prognostic implications of primary colorectal tumor location on recurrence and overall survival in patients undergoing resection for colorectal liver metastasis. J Surg Oncol 2016; 114(7): 803–809, https://doi.org/10.1002/jso.24425.
Mavros M.N., Hyder O., Pulitano C., Aldrighetti L., Pawlik T.M. Survival of patients operated for colorectal liver metastases and concomitant extra-hepatic disease: external validation of a prognostic model. J Surg Oncol 2013; 107(5); 481–485, https://doi.org/10.1002/jso.23260.
Kim C.W., Kim J.I., Park S.H., Han J.Y., Kim J.K., Chung K.W., Sun H.S. Usefulness of plasma tumor M2-pyruvate kinase in the diagnosis of gastrointestinal cancer. Korean J Gastroenterol 2003; 42(5): 387–393.
Dombrauckas J.D., Santarsiero B.D., Mesecar A.D. Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis. Biochemistry 2005; 44(27): 9417–9429, https://doi.org/10.1021/bi0474923.
Zaccaro C., Saracino I.M., Fiorini G., Figura N., Holton J., Castelli V., Pesci V., Gatta L., Vaira D. Power of screening tests for colorectal cancer enhanced by high levels of M2-PK in addition to FOBT. Intern Emerg Med 2017; 12(3): 333–339, https://doi.org/10.1007/s11739-017-1610-3.
Guan M., Tong Y., Guan M., Liu X., Wang M., Niu R., Zhang F., Dong D., Shao J., Zhou Y. Lapatinib inhibits breast cancer cell proliferation by influencing PKM2 expression. Technol Cancer Res Treat 2018; 17: 1533034617749418, https://doi.org/10.1177/1533034617749418.
Tee S.S., Park J.M., Hurd R.E., Brimacombe K.R., Boxer M.B., Massoud T.F., Rutt B.K., Spielman D.M. PKM2 activation sensitizes cancer cells to growth inhibition by 2-deoxy-D-glucose. Oncotarget 2017; 8(53): 90959–90968, https://doi.org/10.18632/oncotarget.19630.
Krones A., Jungermann K., Kietzmann T. Cross-talk between the signals hypoxia and glucose at the glucose response element of the L-type pyruvate kinase gene. Endocrinology 2001; 142(6): 2707–2718, https://doi.org/10.1210/endo.142.6.8200.
Fung K.Y., Tabor B., Buckley M.J., Priebe I.K., Purins L., Pompeia C., Brierley G.V., Lockett T., Gibbs P., Tie J., McMurrick P., Moore J., Ruszkiewicz A., Nice E., Adams T.E., Burgess A., Cosgrove L.J. Blood-based protein biomarker panel for the detection of colorectal cancer. PLoS One 2015; 10(3): e0120425, https://doi.org/10.1371/journal.pone.0120425.
Jenkins C.A., Lewis P.D., Dunstan P.R., Harris D.A. Role of Raman spectroscopy and surface enhanced Raman spectroscopy in colorectal cancer. World J Gastrointest Oncol 2016; 8(5): 427–438, https://doi.org/10.4251/wjgo.v8.i5.427.
Sankiewicz A., Lukaszewski Z., Trojanowska K., Gorodkiewicz E. Determination of collagen type IV by Surface Plasmon Resonance Imaging using a specific biosensor. Anal Biochem 2016; 515: 40–46, https://doi.org/10.1016/j.ab.2016.10.002.
Jain R., Rawat A., Verma B., Markiewski M.M., Weidanz J.A. Antitumor activity of a monoclonal antibody targeting major histocompatibility complex class I-Her2 peptide complexes. J Natl Cancer Inst 2013; 105(3): 202–218, https://doi.org/10.1093/jnci/djs521.
Kang Y.R., Byun J.S., Kim T.J., Park H.G., Park J.C., Barange N., Nam K.H., Kim Y.D. Monitoring of the binding between EGFR protein and EGFR aptamer using in-situ total internal reflection ellipsometry. J Nanosci Nanotechnol 2016; 16(6): 6445–6449, https://doi.org/10.1166/jnn.2016.12123.
Loitsch S.M., Shastri Y., Stein J. Stool test for colorectal cancer screening — it’s time to move! Clin Lab 2008; 54(11–12): 473–484.
Jonkheijm P., Weinrich D., Schröder H., Niemeyer C.M., Waldmann H. Chemical strategies for generating protein biochips. Angew Chem Int Ed Engl 2008; 47(50): 9618–9647, https://doi.org/10.1002/anie.200801711.
Rykhlitskiy S.V., Kruchinin V.N., Shvets V.A., Spesivtsev E.V., Prokop’ev V.Yu. Spectral plasmon-ellipsometric complex ELLIPS-SPEC. Pribory i tekhnika eksperimenta 2013; 1: 137–138, https://doi.org/10.7868/s0032816212060092.
Kikawada M., Ono A., Inami W., Kawata Y. Plasmon-enhanced autofluorescence imaging of organelles in label-free cells by deep-ultraviolet excitation. Anal Chem 2016; 88(2): 1407–1411, https://doi.org/10.1021/acs.analchem.5b04060.
Handbook of ellipsometry. Tompkins H.G., Irene E.A. (editors). Springer Berlin Heidelberg; 2005; 789 p., https://doi.org/10.1007/3-540-27488-x.
Bye W.A., Nguyen T.M., Parker C.E., Jairath V., East J.E. Strategies for detecting colon cancer in patients with inflammatory bowel disease. Cochrane Database Syst Rev 2017; 9: CD000279, https://doi.org/10.1002/14651858.cd000279.pub4.
Chekulayev V., Mado K., Shevchuk I., Koit A., Kaldma A., Klepinin A., Timohhina N., Tepp K., Kandashvili M., Ounpuu L., Heck K., Truu L., Planken A., Valvere V., Kaambre T. Metabolic remodeling in human colorectal cancer and surrounding tissues: alterations in regulation of mitochondrial respiration and metabolic fluxes. Biochem Biophys Rep 2015; 4: 111–125, https://doi.org/10.1016/j.bbrep.2015.08.020.
Meng W., Zhu H.H., Xu Z.F., Cai S.R., Dong Q., Pan Q.R., Zheng S., Zhang S.Z. Serum M2-pyruvate kinase: a promising non-invasive biomarker for colorectal cancer mass screening. World J Gastrointest Oncol 2012; 4(6): 145–151, https://doi.org/10.4251/wjgo.v4.i6.145.
Abdullah M., Rani A.A., Simadibrata M., Fauzi A., Syam A.F. The value of fecal tumor M2 pyruvate kinase as a diagnostic tool for colorectal cancer screening. Acta Med Indones 2012; 44(2): 94–99.
Parente F., Marino B., Ilardo A., Fracasso P., Zullo A., Hassan C., Moretti R., Cremaschini M., Ardizzoia A., Saracino I., Perna F., Vaira D. A combination of faecal tests for the detection of colon cancer: a new strategy for an appropriate selection of referrals to colonoscopy? A prospective multicentre Italian study. Eur J Gastroenterol Hepatol 2012; 24(10): 1145–1152, https://doi.org/10.1097/meg.0b013e328355cc79.
Haug U., Rothenbacher D., Wente M.N., Seiler C.M., Stegmaier C., Brenner H. Tumour M2-PK as a stool marker for colorectal cancer: comparative analysis in a large sample of unselected older adults vs colorectal cancer patients. Br J Cancer 2007; 96(9): 1329–1334, https://doi.org/10.1038/sj.bjc.6603712.

Kruchinin V.N., Kruchinina M.V., Prudnikova Ya.I., Spesivtsev E.V., Rykhlitskiy S.V., Peltek S.E., Shehovtsov S.V., Shuvalov G.V. Ellipsometry Analytical Complex for Measuring near the Surface Plasmon Resonance in Colorectal Cancer Diagnosis. Sovremennye tehnologii v medicine 2019; 11(2): 69, https://doi.org/10.17691/stm2019.11.2.10